Khanh-Thien Le

Khanh-Thien Le

Auto-generated profile, based on publicly available information

Khanh-Thien Le

Faculty of Biology and Biotechnology, University of Science, Ho Chi Minh City, Vietnam

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2023 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
KLKhanh-Thien Le
Khanh-Thien Le
CNCong-Thuan Nguyen
Cong-Thuan Nguyen
TLThuy-Dung Lac
Thuy-Dung Lac
LNLe-Giang Thi Nguyen
Le-Giang Thi Nguyen
LTLinh Thuoc Tran
Linh Thuoc Tran
HTHieu Tran-Van
Hieu Tran-Van

1 November 2020 in Growth Factors
Verified
Journal Article
Closed access
TTThu-Minh Tran-Nguyen
Thu-Minh Tran-Nguyen
KLKhanh-Thien Le
Khanh-Thien Le
LNLe-Giang Thi Nguyen
Le-Giang Thi Nguyen
TTThanh-Loan Thi Tran
Thanh-Loan Thi Tran
PHPhuong-Cac Hoang-Thai
Phuong-Cac Hoang-Thai
HTHieu Tran-Van
Hieu Tran-Van
Fibroblast growth factor 2 (FGF-2) is a multifunctional protein that has major roles in wound healing, tissue repair, and regeneration. This therapeutic protein is widely used for burn treatment because it can stimulate cell proliferation and differentiation, angiogenesis, and extracellular matrix remodeling. In this study, we developed a simple method using a controlled heated brass rod to create a homogenous third-degree burn murine model and evaluated the treatment using recombinant human FGF-2 (rhFGF-2). The results indicated that the wound area was 0.83 ± 0.05 cm2 and wound depth was 573.42 ± 147.82 μm. Mice treated with rhFGF-2 showed higher rates of wound closure, granulation tissue formation, angiogenesis, and re-epithelialization than that of phosphate-buffered saline (PBS)-treated group. In conclusion, our lab-made rhFGF-2 could be a potentially therapeutic protein for burn treatment as well as a bioequivalent drug for other commercial applications using FGF-2.